How much funding has Surge raised?

Surge has raised $10.8M in total funding, most recently a Series B round.

Who are Surge's investors?

Surge's investors include Eurazeo, Hcvc, Kima Ventures, Teampact Ventures, MH Innov.

Where is Surge headquartered?

Surge is headquartered in Paris, France.

Surge

Paris, France · Founded 2021 · $10.8M raised

Medtech

Headquarters: Paris
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: surge.care
Total Funding: $10.8M
Last Round: $8.3M Series BMar 2024
Rounds: 2

About

SurgeCare is a Paris-based medtech company, born from ten years of Stanford University immunology research, that decrypts each patient's hidden immune signature to advance precision medicine. The platform applies single-cell omics technologies and machine learning to reveal early immune signatures that predict medical outcomes including surgical complications, trauma responses, and implant rejection. Founded by Stanford physician-scientist Brice Gaudilliere and biomedical informatics expert Julien Hedou, Surge delivers actionable clinical insights that enable personalized perioperative care and improved patient outcomes.

Summary

Surge is a Medtech company based in Paris, France, founded in 2021. It has raised $10.8M in total across 2 rounds, most recently a $8.3M Series B round in Mar 2024. Investors include Eurazeo, Hcvc and Kima Ventures.